Clinical trials are too slow and too costly—here is how to fix themOur podcast on science and technology. This week, we examine why this mainstay of modern medicine is ailing, and meet the people trying to make it all betterMay 24th 2023CLINICAL TRIALS are the gold standard for testing the safety and efficacy of a treatment or drug, and a keystone in modern medicine.. But their grinding timelines and skyrocketing price tags are hindering development and, ultimately, costing lives…..
https://www.economist.com/clinical-trials-pod?
.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyshicience.Listen on: Apple Podcasts | Spotify | Google | Stitcher | TuneInThis podcast by The Economist opens up questions of how to do effective reasonably priced clinical trials
Clinical trials are too slow and too costly—here is how to fix...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.44M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.5¢ | 10.5¢ | $132.0K | 1.162M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 535926 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 12.5¢ | 10.5¢ | 991112 | ||
| Last updated 15.53pm 03/05/2024 ? | |||||
| SPL (ASX) Chart |